Skip to main content

Daunorubicin News

FDA Approves Vyxeos (daunorubicin and cytarabine) Liposome for Injection for Certain Types of Poor-Prognosis Acute Myeloid Leukemia

August 3, 2017 – The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML)...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Acute Myeloid Leukemia

Daunorubicin patient information at Drugs.com